New — Free Peptide Starter Guide (2026): 13 chapters, 34 cited studies

Get it free
ToolsCompareProstamax vs SNAP-8

Prostamax vs SNAP-8

Side-by-side comparison of key properties, dosing, and research.

Anti-Aging & Longevity
Prostamax
Skin & Cosmetic
SNAP-8
Summary
Prostamax is a tetrapeptide bioregulator (Lys-Glu-Asp-Pro) developed by Professor Vladimir Khavinson, tissue-specific for the prostate gland. It supports prostate epithelial cell function, promotes normalization of prostate tissue, and is studied for its potential in benign prostatic hyperplasia (BPH), prostatitis, and prostate anti-aging. It is one of the more widely used Khavinson bioregulators among men over 40.
SNAP-8 is a synthetic octapeptide cosmetic ingredient that reduces the depth of expression lines and wrinkles by competitively inhibiting the SNARE complex involved in acetylcholine release at neuromuscular junctions, providing a topical 'Botox-like' effect.
Half-Life
Short (minutes); sustained gene-regulatory effects
N/A — topical application; local effect duration depends on formulation
Admin Route
SubQ, Oral
Topical
Research
Typical Dose
10 mg per day
3–10% concentration in formulation
Frequency
Daily for 10–30 days
1–2x daily
Key Benefits
  • Supports normalization of prostate tissue architecture
  • May reduce prostate enlargement associated with BPH
  • Anti-inflammatory effects on prostatic tissue
  • Reduces prostate cell apoptosis from oxidative stress
  • Potential support in chronic prostatitis
  • Anti-aging effects on prostate glandular tissue
  • Complementary to conventional BPH therapies
  • Reduces depth of dynamic expression wrinkles
  • Smooths forehead lines, crow's feet, glabellar lines
  • Non-invasive topical Botox alternative
  • Can be incorporated into serums, creams, eye contour products
  • Reduces muscle contraction without paralysis
  • Improves skin texture and firmness over time
  • Complements other anti-aging peptides (Argireline, Matrixyl)
Side Effects
  • Generally well tolerated in available research
  • Mild injection site reactions
  • No significant adverse urological events reported at standard doses
  • Generally excellent tolerability
  • Rare: mild redness in sensitive individuals
  • Not suitable for injection (topical use only)
Stacks With